Literature DB >> 22287022

Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis.

Angelica Olivo-Diaz1, Mirza Romero-Valdovinos, Areli Gudiño-Ramirez, Jesus Reyes-Gordillo, Diego Emiliano Jimenez-Gonzalez, Maria Elena Ramirez-Miranda, Williams Arony Martinez-Flores, Fernando Martinez-Hernandez, Ana Flisser, Pablo Maravilla.   

Abstract

The intestinal protozoan parasite Blastocystis is one of the most common parasites worldwide in humans and, although its ability to cause human disease has been questioned, some reports have demonstrated that this microorganism is associated to the development of irritable bowel syndrome (IBS) and to a proinflammatory response, in which the expression of some cytokines is unregulated. Since inflammatory cytokine gene polymorphisms might have a role in the pathophysiology of IBS, we assessed the role of single nucleotide polymorphisms (SNPs) for interleukin (IL)-8 and IL-10, in previously collected DNA samples from IBS patients and controls, with or without Blastocystis infection. IL-8+396(G) and IL-10-1082 (A) alleles (p=0.0437 and p=0.0267, respectively), as well as their homozygous (p<0.0001 and p=0.0039, respectively) and IL-8+781(CT) (p=0.0248) genotypes were significantly overrepresented in patients with IBS in comparison with controls. IL-8+396(GG) genotype was relevant because it was associated to IBS (p<0.0001), to Blastocystis (p=0.0025), and to IBSBlastocystis (p=0.0272). In the latter binomial association, this genotype presented a high contribution (etiological fraction =0.452) and a risk >fourfold to develop IBS. IL-8+781 (T) and IL-10-592 (C) alleles were also associated to Blastocystis and to IBSBlastocystis, respectively (p=0.0448 and p=0.0166). Our results suggest that some IL-8 and IL-10 SNPs could change individual susceptibility increasing the relative risk in the development of IBS in Blastocystis carriers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287022     DOI: 10.1007/s00436-012-2830-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  26 in total

1.  T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome.

Authors:  Elham Barkhordari; Nima Rezaei; Mahdi Mahmoudi; Pegah Larki; Hamid Reza Ahmadi-Ashtiani; Bita Ansaripour; Maryam Alighardashi; Mohammad Bashashati; Ali Akbar Amirzargar; Naser Ebrahimi-Daryani
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

2.  DQA1 and DQB1 association and nasal polyposis.

Authors:  Germán Fajardo-Dolci; Jesús Solorio-Abreu; Julio César Romero-Alvarez; Beatríz Zavaleta-Villa; Oscar Cerezo-Camacho; Rocío Jiménez-Lucio; Angélica Olivo-Díaz
Journal:  Otolaryngol Head Neck Surg       Date:  2006-08       Impact factor: 3.497

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

Authors:  W M Gonsalkorale; C Perrey; V Pravica; P J Whorwell; I V Hutchinson
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Detection of Blastocystis hominis in unpreserved stool specimens by using polymerase chain reaction.

Authors:  Rune Stensvold; Anna Brillowska-Dabrowska; Henrik Vedel Nielsen; Maiken Cavling Arendrup
Journal:  J Parasitol       Date:  2006-10       Impact factor: 1.276

Review 6.  Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.

Authors:  D Stark; S van Hal; D Marriott; J Ellis; J Harkness
Journal:  Int J Parasitol       Date:  2006-10-12       Impact factor: 3.981

7.  Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis.

Authors:  Javed Yakoob; Wasim Jafri; Nadim Jafri; Rustam Khan; Muhammad Islam; M Asim Beg; Viqar Zaman
Journal:  Am J Trop Med Hyg       Date:  2004-04       Impact factor: 2.345

8.  Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite.

Authors:  C R Stensvold; H C Lewis; A M Hammerum; L J Porsbo; S S Nielsen; K E P Olsen; M C Arendrup; H V Nielsen; K Mølbak
Journal:  Epidemiol Infect       Date:  2009-04-27       Impact factor: 2.451

Review 9.  Genetic determination of irritable bowel syndrome.

Authors:  Cristina Hotoleanu; Radu Popp; Adrian-Pavel Trifa; Laurentiu Nedelcu; Dan-L Dumitrascu
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

10.  Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily.

Authors:  W S Modi; M Dean; H N Seuanez; N Mukaida; K Matsushima; S J O'Brien
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

View more
  20 in total

1.  Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection.

Authors:  Mei Xing Lim; Chin Wen Png; Crispina Yan Bing Tay; Joshua Ding Wei Teo; Huipeng Jiao; Norbert Lehming; Kevin Shyong Wei Tan; Yongliang Zhang
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.

Authors:  Shan-Yu Qin; Hai-Xing Jiang; Dong-Hong Lu; You Zhou
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.

Authors:  Ayman A El-Badry; Wegdan M Abd El Wahab; Doaa A Hamdy; Alaa Aboud
Journal:  Parasitol Res       Date:  2017-11-14       Impact factor: 2.289

4.  Blastocystis spp., Cryptosporidium spp., and Entamoeba histolytica exhibit similar symptomatic and epidemiological patterns in healthcare-seeking patients in Karachi.

Authors:  Syeda Sadaf Haider; Rakhshanda Baqai; Fouad M Qureshi; Kenneth Boorom
Journal:  Parasitol Res       Date:  2012-07-05       Impact factor: 2.289

Review 5.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome.

Authors:  Mirza Romero-Valdovinos; Areli Gudiño-Ramírez; Jesús Reyes-Gordillo; Williams Arony Martínez-Flores; María Elena Ramírez-Miranda; Pablo Maravilla; Angélica Olivo-Díaz
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

7.  Features of Blastocystis spp. in xenic culture revealed by deconvolutional microscopy.

Authors:  Robyn Nagel; Christian Gray; Helle Bielefeldt-Ohmann; Rebecca J Traub
Journal:  Parasitol Res       Date:  2015-05-22       Impact factor: 2.289

8.  Blastocystis Isolates from Patients with Irritable Bowel Syndrome and from Asymptomatic Carriers Exhibit Similar Parasitological Loads, but Significantly Different Generation Times and Genetic Variability across Multiple Subtypes.

Authors:  Gie-Bele Vargas-Sanchez; Mirza Romero-Valdovinos; Celedonio Ramirez-Guerrero; Ines Vargas-Hernandez; Maria Elena Ramirez-Miranda; Joel Martinez-Ocaña; Alicia Valadez; Cecilia Ximenez; Eduardo Lopez-Escamilla; Maria Elena Hernandez-Campos; Guiehdani Villalobos; Fernando Martinez-Hernandez; Pablo Maravilla
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

9.  Association between interleukin 8-251 T/A and +781 C/T polymorphisms and glioma risk.

Authors:  Hao Liu; Ping Mao; Changhou Xie; Wanfu Xie; Maode Wang; Haitao Jiang
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

10.  Diagnosis and subtype analysis of Blastocystis sp. in 442 patients in a hospital setting in the Netherlands.

Authors:  Aldert Bart; Ellen M S Wentink-Bonnema; Henk Gilis; Nienke Verhaar; Carla J A Wassenaar; Michèle van Vugt; Abraham Goorhuis; Tom van Gool
Journal:  BMC Infect Dis       Date:  2013-08-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.